Literature DB >> 10921808

Migraine: pharmacotherapy in the emergency department.

A M Kelly1.   

Abstract

Migraine can be a disabling condition for the sufferer. For the small number of patients who fail home therapy and seek treatment in an emergency department, there are a number of therapeutic options. This paper reviews the evidence regarding the effectiveness and safety of the following therapies: the phenothiazines, lignocaine (lidocaine), ketorolac, the ergot alkaloids, metoclopramide, the "triptans", haloperidol, pethidine and magnesium. Based on available evidence, the most effective agents seem to be prochlorperazine, chlorpromazine and sumatriptan, each of which have achieved greater then 70% efficacy in a number of studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921808      PMCID: PMC1725423          DOI: 10.1136/emj.17.4.241

Source DB:  PubMed          Journal:  J Accid Emerg Med        ISSN: 1351-0622


  4 in total

1.  Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial.

Authors:  Catherine Buettner; Agustin Melo-Carrillo; Rami Burstein
Journal:  Headache       Date:  2017-03       Impact factor: 5.887

Review 2.  Rizatriptan: an update of its use in the management of migraine.

Authors:  Keri Wellington; Greg L Plosker
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Ketorolac versus Magnesium Sulfate in Migraine Headache Pain Management; a Preliminary Study.

Authors:  Hossein Delavar Kasmaei; Marzieh Amiri; Ahmed Negida; Samaneh Hajimollarabi; Nastaransadat Mahdavi
Journal:  Emerg (Tehran)       Date:  2017-01-08

4.  Metoclopramide versus sumatriptan for treatment of migraine headache: A randomized clinical trial.

Authors:  Saeid Talabi; Babak Masoumi; Reza Azizkhani; Mehrdad Esmailian
Journal:  J Res Med Sci       Date:  2013-08       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.